Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Palamur Biosciences Faces USFDA Warning for Multiple GLP Compliance Failures

USFDA places clinical hold on Gilead Sciences trials testing HIV pill combination

Written By Ruchika Sharma11 Jun 2025 12:13 PM IST

Foster City: Gilead Sciences has announced that the U.S. Food and Drug Administration has placed a clinical hold on its HIV treatment trials...

Granules India packaging facility in US successfully completes USFDA inspection

USFDA inspection: Zydus gets EIR for Dabhasa API manufacturing facility

Written By Ruchika Sharma10 Jun 2025 1:24 PM IST

Ahmedabad: Zydus has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration...

USFDA Closes Inspection at Zydus Ankleshwar Unit-2 With Three Observations

USFDA classifies OneSource Bangalore drug-device combination facility as VAI

Written By Ruchika Sharma10 Jun 2025 12:00 PM IST

Bangalore: OneSource Specialty Pharma Limited, a multi-modality specialty pharma pure-play CDMO, has announced that its flagship facility in...

Merck RSV antibody Enflonsia gets USFDA okay for infants

Written By Ruchika Sharma10 Jun 2025 11:06 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has received approval from the U.S. Food and Drug Administration (FDA)...

Merck posts positive phase 3 trials results evaluating Enlicitide Decanoate in adults with Hyperlipidemia

Written By Ruchika Sharma10 Jun 2025 9:00 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced positive topline results from the first two of three...

Maha: Rs 14-Crore Mephedrone Unit Busted Near Police Station, Cop Suspended for Negligence

Illegal drugs manufacturing unit busted in Haridwar

Written By Ruchika Sharma9 Jun 2025 4:35 PM IST

New Delhi: In a significant crackdown on illegal drug operations, the Narcotics Control Bureau (NCB) has uncovered an illicit drug-manufacturing unit...

Sanofis Thyrotropin Alfa Label Update: CDSCO Panel Recommends New Prescription Warning, Limits Sale to Specialists Only

Sanofi-Regeneron Dupixent data reinforce use in atopic dermatitis patients with skin of color

Written By Ruchika Sharma9 Jun 2025 1:12 PM IST

Paris: Sanofi has announced that results from the DISCOVER phase 4, single-arm, open-label study assessing Dupixent (dupilumab) in adults and...

Bayer Finerenone approved in Japan for chronic heart failure

Simultaneous treatment start with Finerenone and SGLT-2-inhibitor demonstrated positive data in patients with CKD associated with type 2 diabetes: Bayer

Written By Ruchika Sharma9 Jun 2025 10:00 AM IST

Berlin: Bayer has announced results of the Phase II CONFIDENCE study, demonstrating that simultaneous initiation of finerenone (Kerendia)...

Banned medicated soap found in Karimnagar medical shop raid

Written By Ruchika Sharma8 Jun 2025 4:15 PM IST

Telangana: Drugs Control Administration, Telangana, has seized a banned drug, 'Medicated Skin Care Soap containing Permethrin IP 1.0%, Cetrimide IP...

No False Advertising Found: US Court Rejects Bayer Plea to Block Erleada Ads

Bayer arm secures exclusive worldwide rights to develop, commercialize clinical-stage WRN Inhibitor

Written By Ruchika Sharma8 Jun 2025 10:00 AM IST

San Diego: Vividion Therapeutics, Inc., a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of...

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin bags tentative nod from USFDA for partial-onset seizures drug Oxcarbazepine ER

Written By Ruchika Sharma7 Jun 2025 5:24 PM IST

Mumbai: Lupin Limited has announced that it has received tentative approval from the United States Food and Drug Administration (U.S. FDA) for...

Eye condition NAION is a very rare side effect of semaglutide: EMA safety committee

EMA flags rare vision risk with Semaglutide- a active substance in Ozempic, Rybelsus, Wegovy

Written By Ruchika Sharma7 Jun 2025 4:52 PM IST

European Medicines Agency (EMA)'s safety committee (PRAC) has concluded its review of medicines containing semaglutide following concerns...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok